University of Alabama Birmingham- Nephrology- Site Number : 840018 — Birmingham, Alabama

University of Alabama Birmingham- Nephrology- Site Number : 840018 is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Alabama Birmingham- Nephrology- Site Number : 840018 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Fabry Disease.

Sponsors: Genzyme, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama Birmingham- Nephrology- Site Number : 840018?

University of Alabama Birmingham- Nephrology- Site Number : 840018 has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama Birmingham- Nephrology- Site Number : 840018 conducted?

University of Alabama Birmingham- Nephrology- Site Number : 840018 has 2 clinical trials on record, with 2 currently active. Their work covers Fabry Disease.

Is University of Alabama Birmingham- Nephrology- Site Number : 840018 accredited by Crixeo Clinical Trials?

University of Alabama Birmingham- Nephrology- Site Number : 840018 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama Birmingham- Nephrology- Site Number : 840018?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.